Margaret Moore, MD

Hematopathology

Margaret Moore, MD Assistant Professor of Hematopathology

Department: Pathology

Phone: 804-628-5780

Fax: 804-828-2812

Margaret Moore, MD is currently an Assistant Professor of Hematopathology at Virginia Commonwealth University.

Dr. Moore completed medical school, anatomic and clinical pathology residency, and hematopathology fellowship at the University of Virginia (UVA). She then practiced as a surgical pathologist and hematopathologist at UVA for one year, prior to accepting her current appointment at VCU.

Her clinical and research interests include benign and malignant disorders of the blood, bone marrow, and lymphoid tissues. She has authored multiple peer-reviewed articles, as well as educational hematopathology modules. She enjoys working with trainees of all levels.

Contact Dr. Moore for a full CV

Print/Download Dr. Moore Web CV (pdf)

Dr. Margaret Moore abbreviated CV

Education

July 2023 - June 2024
University of Virginia, Charlottesville, Virginia Fellow, Hematopathology

July 2019 - June 2023
University of Virginia, Charlottesville, Virginia
Resident, Anatomic and Clinical Pathology

August 2015 - May 2019
University of Virginia, Charlottesville, Virginia
Doctor of Medicine

August 2010 - May 2014
University of Richmond, Richmond, Virginia
Bachelor of Science in Biochemistry,
summa cum laude

Licenses & Certifications

October 2022 - Present: Virginia Medical License

Selected Awards & Honors

June 2023 UVA Resident Citizenship Award

April 2023 UVA Pathology Research Day, Best Clinical Research Poster

May 2019 Dr. James R. Cash Pathology Book Award

January 2017 Alpha Omega Alpha Honor Society

Professional Service (outside)

July 2025 - Present International Clinical Cytometry Society

April 2023 - Present Society for Hematopathology

January 2020 - Present American Society of Clinical Pathology

January 2020 - Present United States and Canadian Academy of Pathology

July 2019 - Present Virginia Society for Pathology

July 2019 - Present College of American Pathologists

Selected Publications

Peer Reviewed

Moore M, Patel P, Tao J. Concurrent involvement of the bone marrow by BRAF V600E–mutant melanoma and hairy cell leukemia. J Hematopathol. 2024;17(4):223-225. doi:10.1007/s12308-024-00609-3

Moore M, Aguilera NS, Obiorah I, et al. Assessment for acceleration and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma using histologic and immunohistochemical features: a case series. J Hematopathol. 2024;17(3):139-147. doi:10.1007/s12308-024-00598-3

Moore M, Chen X, Sadigh S, et al. Evaluating pathologist practices in peripheral blood smear review: A comprehensive practice survey. American Journal of Clinical Pathology. Published online July 22, 2024:aqae091. doi:10.1093/ajcp/aqae091

Moore M, Williams E, Pelkey L, et al. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists. Cancer Genetics. 2024;286-287:25-28. doi:10.1016/j.cancergen.2024.06.003.

Moore M, Courville E, Prakash S, et al. An interactive e-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. American Journal of Clinical Pathology. 2023;aqad014.

Moore M, Courville E. Work-up of patients with decreased hemoglobin A2 identified by capillary zone electrophoresis, a North American institutional experience. Laboratory Medicine. 2022;XX:e0–e6.

Abstracts and Presentations

* Indicates meeting presenter
Bolte F, Natale N, DiBenedetto S, Moore M, et al. Spatial transcriptomics of the tumor microenvironment reveals different interferon-related gene signatures in tumor endothelial cells of patients with EGFR and KRAS mutant non-small cell lung cancer. Submitted to American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.

Moore M, Courville E, Craig J, et al. Characteristic blast morphology and immunophenotype assist in identification of trisomy 21 in a setting of limited prenatal care. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.

Moore M, Aguilera N. Peripheral T-cell lymphoma, not otherwise specified, in a robust histiocytic background, an unusual presentation with Pott’s-Puffy tumor. Accepted to 2025 Society for Hematopathology/European Association for Haematopathology Joint Workshop Meeting.

*Moore M. Society for hematopathology education committee results: Pathologist practices in peripheral blood smear review. Society for Hematopathology Program Directors Meeting. USCAP 2024.

Pelkey L, Moore M, El Chaer F, et al. A comparison of World Health Organization and International Consensus Classification systems for myeloid neoplasms and implications for pathology reporting. Abstracts and Case studies from the College of American pathologists 2023 annual meeting(Cap23). Archives of Pathology & Laboratory Medicine. 2023;147(9):e2-e154

*Moore M, Prakash S, Brown L, et al. An interactive E-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. USCAP 2023 abstracts education. Laboratory Investigation. 2023;103(3):100086.

*Moore M, Aguilera N, Obiorah I, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with features of acceleration/transformation is difficult to define by histologic or immunohistochemical criteria. USCAP 2023 abstracts hematopathology. Laboratory Investigation. 2023;103(3):100106.